|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 701 to 800 out of 849 for Mif

0.471s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: macaque, rhesus
Publication
First Author: Leng L
Year: 2003
Journal: J Exp Med
Title: MIF signal transduction initiated by binding to CD74.
Volume: 197
Issue: 11
Pages: 1467-76
Publication
First Author: Nagarajan P
Year: 2014
Journal: Mol Cancer Res
Title: MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma.
Volume: 12
Issue: 9
Pages: 1292-302
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Publication
First Author: Alfahel L
Year: 2024
Journal: Cell Rep Med
Title: Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
Volume: 5
Issue: 5
Pages: 101546
Publication
First Author: Zheng Y
Year: 2015
Journal: Nat Cell Biol
Title: Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation.
Volume: 17
Issue: 10
Pages: 1348-55
Publication
First Author: Alaskarov A
Year: 2022
Journal: Sci Rep
Title: MIF homolog d-dopachrome tautomerase (D-DT/MIF-2) does not inhibit accumulation and toxicity of misfolded SOD1.
Volume: 12
Issue: 1
Pages: 9570
Publication
First Author: Suresh V
Year: 2022
Journal: FASEB J
Title: MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway-induced p53-dependent apoptosis.
Volume: 36
Issue: 8
Pages: e22449
Publication
First Author: Mun SH
Year: 2013
Journal: J Bone Miner Res
Title: Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.
Volume: 28
Issue: 4
Pages: 948-59
Publication  
First Author: Schulz R
Year: 2014
Journal: Cell Death Dis
Title: HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
Volume: 5
Pages: e980
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Publication
First Author: Korf H
Year: 2017
Journal: PLoS One
Title: MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset.
Volume: 12
Issue: 11
Pages: e0187455
Allele  
Name: SMT3 suppressor of mif two 3 homolog 2, pseudogene 2 (S. cerevisiae); wild type
Allele Type: Not Specified
Allele  
Name: SMT3 suppressor of mif two 3 homolog 2, pseudogene (S. cerevisiae); wild type
Allele Type: Not Specified
Protein
Organism: Mus musculus/domesticus
Length: 115  
Fragment?: false
Publication
First Author: Leyton-Jaimes MF
Year: 2019
Journal: Proc Natl Acad Sci U S A
Title: AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
Volume: 116
Issue: 29
Pages: 14755-14760
GO Term
Publication
First Author: Nishioka Y
Year: 1989
Journal: Cytogenet Cell Genet
Title: Genome comparison in the genus Mus: a study with B1, MIF (mouse interspersed fragment), centromeric, and Y-chromosomal repetitive sequences.
Volume: 50
Issue: 4
Pages: 195-200
Allele
Name: macrophage migration inhibitory factor (glycosylation-inhibiting factor); endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Allele
Name: macrophage migration inhibitory factor (glycosylation-inhibiting factor); endonuclease-mediated mutation 3, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Humanized sequence, Inserted expressed sequence
Publication  
First Author: Seidel F
Year: 2022
Journal: Int J Mol Sci
Title: Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice.
Volume: 23
Issue: 18
GO Term
GO Term
GO Term
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
HT Experiment  
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: ArrayExpress
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: Mus caroli
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: mouse, laboratory
Pseudogene
Type: pseudogene
Organism: Mus spretus
Publication
First Author: Brunkow ME
Year: 2001
Journal: Nat Genet
Title: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.
Volume: 27
Issue: 1
Pages: 68-73
Allele
Name: transgene insertion 279, Douglas Arenberg
Allele Type: Transgenic
Attribute String: Inducible, Inserted expressed sequence
Strain
Attribute String: mutant strain, transgenic
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: ArrayExpress
Publication
First Author: Sugimoto H
Year: 1999
Journal: Biochemistry
Title: Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
Volume: 38
Issue: 11
Pages: 3268-79
Publication
First Author: Van Molle W
Year: 2005
Journal: Eur J Immunol
Title: How glucocorticoids control their own strength and the balance between pro- and anti-inflammatory mediators.
Volume: 35
Issue: 12
Pages: 3396-9
Publication
First Author: Matsunaga J
Year: 1999
Journal: Cell Mol Biol (Noisy-le-grand)
Title: Macrophage migration inhibitory factor (MIF)--its role in catecholamine metabolism.
Volume: 45
Issue: 7
Pages: 1035-40
Protein Domain
Type: Conserved_site
Description: Macrophage migration inhibitory factor (MIF) is a key regulatory cytokine within innate and adaptive immune responses, capable of promoting and modulating the magnitude of the response []. MIF is released from T-cells and macrophages, and acts within the neuroendocrine system. MIF is capable of tautomerase activity, although its biological function has not been fully characterised. It is induced by glucocorticoid and is capable of overriding the anti-inflammatory actions of glucocorticoid []. MIF regulates cytokine secretion and the expression of receptors involved in the immune response. It can be taken up into target cells in order to interact with intracellular signalling molecules, inhibiting p53 function, and/or activating components of the mitogen-activated protein kinase and Jun-activation domain-binding protein-1 (Jab-1) []. MIF has been linked to various inflammatory diseases, such as rheumatoid arthritis and atherosclerosis [].The MIF homologue D-dopachrome tautomerase () is involved in detoxification through the conversion of dopaminechrome (and possibly norepinephrinechrome), the toxic quinine product of the neurotransmitter dopamine (and norepinephrine), to an indole derivative that can serve as a precursor to neuromelanin [, ].The signature pattern for this entry is formed from a conserved region located in the central section.
Protein Domain
Type: Family
Description: Macrophage migration inhibitory factor (MIF) is a key regulatory cytokine within innate and adaptive immune responses, capable of promoting and modulating the magnitude of the response []. MIF is released from T-cells and macrophages, and acts within the neuroendocrine system. MIF is capable of tautomerase activity, although its biological function has not been fully characterised. It is induced by glucocorticoid and is capable of overriding the anti-inflammatory actions of glucocorticoid []. MIF regulates cytokine secretion and the expression of receptors involved in the immune response. It can be taken up into target cells in order to interact with intracellular signalling molecules, inhibiting p53 function, and/or activating components of the mitogen-activated protein kinase and Jun-activation domain-binding protein-1 (Jab-1) []. MIF has been linked to various inflammatory diseases, such as rheumatoid arthritis and atherosclerosis [].The MIF homologue D-dopachrome tautomerase () is involved in detoxification through the conversion of dopaminechrome (and possibly norepinephrinechrome), the toxic quinine product of the neurotransmitter dopamine (and norepinephrine), to an indole derivative that can serve as a precursor to neuromelanin [, ].
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Publication
First Author: Means GD
Year: 2000
Journal: Genomics
Title: A transcript map of a 2-Mb BAC contig in the proximal portion of the mouse X chromosome and regional mapping of the scurfy mutation.
Volume: 65
Issue: 3
Pages: 213-23
Protein
Organism: Mus musculus/domesticus
Length: 118  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 115  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 73  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 118  
Fragment?: false
Publication
First Author: Donn RP
Year: 2004
Journal: J Endocrinol
Title: Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule.
Volume: 182
Issue: 1
Pages: 1-9
Publication
First Author: Morand EF
Year: 2006
Journal: Nat Rev Drug Discov
Title: MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis.
Volume: 5
Issue: 5
Pages: 399-410
Publication
First Author: Gimm T
Year: 2010
Journal: FASEB J
Title: Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1.
Volume: 24
Issue: 11
Pages: 4443-58
Protein
Organism: Mus musculus/domesticus
Length: 64  
Fragment?: false
Publication
First Author: Togashi A
Year: 2005
Journal: Cancer Res
Title: Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy.
Volume: 65
Issue: 11
Pages: 4817-26
Publication
First Author: Nishimura S
Year: 2011
Journal: Eur J Gynaecol Oncol
Title: Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer.
Volume: 32
Issue: 2
Pages: 146-9
Protein Domain
Type: Family
Description: Hypoxia-inducible lipid droplet-associated protein (HILPDA), also known as hypoxia-inducible protein 2 (HIG2), increases intracellular lipid accumulation. It stimulates expression of cytokines including IL6, MIF and VEGFA. It also enhances cell growth and proliferation [, ]. Human HILPDA is highly expressed in renal cell carcinoma cells but barely detectable in adjacent normal kidney tissue. It is detected in some cervical and endometrial cancers [, , ].
Publication
First Author: Chen A
Year: 1998
Journal: Biochem Mol Biol Int
Title: Characterization of mouse ubiquitin-like SMT3A and SMT3B cDNAs and gene/pseudogenes.
Volume: 46
Issue: 6
Pages: 1161-74